ABSTRACT
OBJECTIVES: To investigate early changes in tumour perfusion parameters by dynamic contrast-enhanced ultrasonography (D-CEUS) and to identify any correlation with survival and tumour response in patients with metastatic colorectal cancer (CRC) treated with bevacizumab (B). METHODS: Thirty-seven patients randomized to either chemotherapy (C) plus B or C alone were considered for this study. D-CEUS was performed at baseline and after the first treatment cycle (day 15). Four D-CEUS perfusion parameters were considered: derived peak intensity (DPI), area under the curve (AUC), slope of wash-in (A) and time to peak intensity (TPI). RESULTS: In patients treated with C plus B, a ≥22.5 % reduction in DPI, ≥20 % increase in TPI and ≥10 % reduction in AUC were correlated with higher progression-free survival in the C+B arm (p = 0.048, 0.024 and 0.010, respectively) but not in the C arm. None of the evaluated parameter modifications had a correlation with tumour response or overall survival. CONCLUSIONS: D-CEUS could be useful for detecting and quantifying dynamic changes in tumour vascularity as early as 15 days after the start of B-based therapy. Although these changes may be predictive of progression-free survival, no correlation with response or overall survival was found. KEY POINTS: ⢠D-CEUS showed early changes in liver metastasis perfusion in colorectal cancer. ⢠A decrease in tumour perfusion was associated with longer progression-free survival. ⢠The decrease in perfusion was not correlated with higher overall survival.
Subject(s)
Bevacizumab/therapeutic use , Colorectal Neoplasms/pathology , Contrast Media , Image Enhancement/methods , Liver Neoplasms/drug therapy , Ultrasonography/methods , Adult , Aged , Aged, 80 and over , Antineoplastic Agents, Immunological/therapeutic use , Area Under Curve , Disease-Free Survival , Female , Humans , Liver/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/secondary , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Treatment OutcomeABSTRACT
INTRODUCTION: We describe a case of acute hiatal hernia during chemotherapy, in a female patient previously treated with gastrectomy. CASE PRESENTATION: After gastric resection, the patient underwent chemotherapy, developing important emetic symptoms. A radiograph of the abdomen was performed because of acute epigastrial pain and it showed a marked left diaphragm elevation.A CT scan carried out 24 hours later identified an occlusion with herniation in the left hemi thorax. Subsequent surgical investigation resulted in a diagnosis of hiatal hernia with volvulus. CONCLUSIONS: This case represents a rare, late complication occurring after gastrectomy.